The following is a partial list of the "C" codes for Medical Subject Headings (MeSH), as defined by the United States National Library of Medicine (NLM).
This list continues the information at List of MeSH codes (C18). Codes following these are found at List of MeSH codes (C20). For other MeSH codes, see List of MeSH codes.
The source for this content is the set of 2006 MeSH Trees from the NLM.
MeSH C19 – endocrine system diseases
MeSH C19.053 – adrenal gland diseases
MeSH C19.053.098 – adrenal cortex diseases
- MeSH C19.053.098.265 – adrenal cortex neoplasms
- MeSH C19.053.098.265.500 – adrenocortical adenoma
- MeSH C19.053.098.265.750 – adrenocortical carcinoma
MeSH C19.053.347 – adrenal gland neoplasms
- MeSH C19.053.347.500 – adrenal cortex neoplasms
- MeSH C19.053.347.500.500 – adrenocortical adenoma
- MeSH C19.053.347.500.750 – adrenocortical carcinoma
MeSH C19.053.440 – adrenal hyperplasia, congenital
MeSH C19.053.500 – adrenal insufficiency
MeSH C19.053.800 – adrenocortical hyperfunction
MeSH C19.246 – diabetes mellitus
MeSH C19.246.099 – diabetes complications
- MeSH C19.246.099.500 – diabetic angiopathies
- MeSH C19.246.099.500.191 – diabetic foot
- MeSH C19.246.099.500.382 – diabetic retinopathy
- MeSH C19.246.099.750 – diabetic coma
- MeSH C19.246.099.750.490 – hyperglycemic hyperosmolar nonketotic coma
- MeSH C19.246.099.812 – diabetic ketoacidosis
- MeSH C19.246.099.875 – diabetic nephropathies
- MeSH C19.246.099.937 – diabetic neuropathies
- MeSH C19.246.099.937.250 – diabetic foot
- MeSH C19.246.099.968 – fetal macrosomia
MeSH C19.246.200 – diabetes, gestational
MeSH C19.246.240 – diabetes mellitus, experimental
MeSH C19.246.267 – diabetes mellitus, type 1
MeSH C19.246.300 – diabetes mellitus, type 2
MeSH C19.246.774 – prediabetic state
MeSH C19.297 – dwarfism
MeSH C19.297.155 – congenital hypothyroidism
MeSH C19.297.312 – dwarfism, pituitary
MeSH C19.297.656 – laron syndrome
MeSH C19.344 – endocrine gland neoplasms
MeSH C19.344.078 – adrenal gland neoplasms
- MeSH C19.344.078.265 – adrenal cortex neoplasms
- MeSH C19.344.078.265.500 – adrenocortical adenoma
- MeSH C19.344.078.265.750 – adrenocortical carcinoma
MeSH C19.344.400 – multiple endocrine neoplasia
MeSH C19.344.410 – ovarian neoplasms
MeSH C19.344.421 – pancreatic neoplasms
- MeSH C19.344.421.249 – adenoma, islet cell
- MeSH C19.344.421.249.500 – insulinoma
- MeSH C19.344.421.500 – carcinoma, islet cell
- MeSH C19.344.421.500.124 – gastrinoma
- MeSH C19.344.421.500.249 – glucagonoma
- MeSH C19.344.421.500.500 – somatostatinoma
- MeSH C19.344.421.500.750 – vipoma
- MeSH C19.344.421.750 – carcinoma, pancreatic ductal
MeSH C19.344.473 – paraneoplastic endocrine syndromes
MeSH C19.344.525 – parathyroid neoplasms
MeSH C19.344.609 – pituitary neoplasms
MeSH C19.344.762 – testicular neoplasms
MeSH C19.344.894 – thyroid neoplasms
MeSH C19.391 – gonadal disorders
MeSH C19.391.482 – hypogonadism
MeSH C19.391.630 – ovarian diseases
- MeSH C19.391.630.050 – anovulation
- MeSH C19.391.630.450 – oophoritis
- MeSH C19.391.630.580 – ovarian cysts
- MeSH C19.391.630.580.765 – polycystic ovary syndrome
- MeSH C19.391.630.611 – ovarian failure, premature
- MeSH C19.391.630.642 – ovarian hyperstimulation syndrome
- MeSH C19.391.630.705 – ovarian neoplasms
- MeSH C19.391.630.705.265 – brenner tumor
- MeSH C19.391.630.705.331 – carcinoma, endometrioid
- MeSH C19.391.630.705.398 – granulosa cell tumor
- MeSH C19.391.630.705.464 – luteoma
- MeSH C19.391.630.705.531 – meigs syndrome
- MeSH C19.391.630.705.648 – sertoli-leydig cell tumor
- MeSH C19.391.630.705.765 – thecoma
MeSH C19.391.690 – puberty, delayed
MeSH C19.391.693 – puberty, precocious
MeSH C19.391.775 – sex differentiation disorders
- MeSH C19.391.775.129 – adrenogenital syndrome
- MeSH C19.391.775.260 – freemartinism
- MeSH C19.391.775.309 – gonadal dysgenesis
- MeSH C19.391.775.309.193 – gonadal dysgenesis, 46,xx
- MeSH C19.391.775.309.388 – gonadal dysgenesis, 46,xy
- MeSH C19.391.775.309.391 – gonadal dysgenesis, mixed
- MeSH C19.391.775.309.872 – turner syndrome
- MeSH C19.391.775.316 – hermaphroditism
- MeSH C19.391.775.316.313 – hermaphroditism, true
- MeSH C19.391.775.316.627 – pseudohermaphroditism
- MeSH C19.391.775.316.627.500 – androgen-insensitivity syndrome
- MeSH C19.391.775.370 – hyperandrogenism
- MeSH C19.391.775.425 – kallmann syndrome
- MeSH C19.391.775.454 – klinefelter syndrome
MeSH C19.391.829 – testicular diseases
MeSH C19.642 – parathyroid diseases
MeSH C19.642.355 – hyperparathyroidism
MeSH C19.642.482 – hypoparathyroidism
MeSH C19.642.713 – parathyroid neoplasms
MeSH C19.700 – pituitary diseases
MeSH C19.700.159 – diabetes insipidus
- MeSH C19.700.159.750 – diabetes insipidus, neurogenic
- MeSH C19.700.159.875 – wolfram syndrome
MeSH C19.700.320 – empty sella syndrome
MeSH C19.700.355 – hyperpituitarism
MeSH C19.700.482 – hypopituitarism
MeSH C19.700.490 – inappropriate adh syndrome
MeSH C19.700.725 – pituitary apoplexy
MeSH C19.700.734 – pituitary neoplasms
MeSH C19.787 – polyendocrinopathies, autoimmune
MeSH C19.874 – thyroid diseases
MeSH C19.874.255 – euthyroid sick syndromes
MeSH C19.874.283 – goiter
- MeSH C19.874.283.300 – goiter, endemic
- MeSH C19.874.283.501 – goiter, nodular
- MeSH C19.874.283.601 – goiter, substernal
- MeSH C19.874.283.605 – Graves' disease
- MeSH C19.874.283.605.500 – Graves' ophthalmopathy
- MeSH C19.874.283.802 – lingual goiter
MeSH C19.874.397 – hyperthyroidism
MeSH C19.874.410 – hyperthyroxinemia
MeSH C19.874.482 – hypothyroidism
MeSH C19.874.689 – thyroid dysgenesis
- MeSH C19.874.689.500 – lingual thyroid
- MeSH C19.874.689.500.500 – lingual goiter
MeSH C19.874.788 – thyroid neoplasms
MeSH C19.874.871 – thyroiditis
MeSH C19.874.902 – thyrotoxicosis
MeSH C19.927 – tuberculosis, endocrine
The list continues at List of MeSH codes (C20).
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.